版本:
中国

BRIEF-Fitch says Mylan's Epipen settlement removes major risk

Oct 10 Fitch:

* Fitch: Mylan's Epipen settlement moves major risk aside

* Mylan will have sufficient liquidity to make settlement payment without derailing expected de-leveraging subsequent to mostly debt-funded acquisition of Meda Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐